Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Greer

Showing results (121-130 of 178) with videos related to

Pageof 18
Sort By:
Leukemia & Lymphoma|May 9, 2001
Is total body irradiation a necessary component of preparative therapy for autologous transplantation in non-Hodgkin's lymphomaR S Stein, J P Greer, S Goodman, et al.
Journal of Crohn'S & Colitis|October 17, 2013
Costs of adalimumab versus infliximab as first-line biological therapy for luminal Crohn's diseaseGrace K H Choi, Stephanie D E Collins, Daniel P Greer, et al.
Technology in Cancer Research & Treatment|September 26, 2019
Investigation of a Novel Decision Support Metric for Head and Neck Adaptive Radiation Therapy Using a Real-Time <i>In Vivo</i> Portal Dosimetry SystemS B Lim, C J Tsai, Y Yu, et al.
Bone Marrow Transplantation|February 16, 2000
Intensified preparative regimens and autologous transplantation in refractory or relapsed intermediate grade non-Hodgkin's lymphomaR S Stein, J P Greer, S Goodman, et al.
Cancer|December 1, 1987
Malignant lymphomas of follicular center cell origin in man. VI. Large cleaved cell lymphomaR S Stein, M J Magee, R K Lenox, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 1, 1995
T-cell-rich B-cell lymphomas: diagnosis and response to therapy of 44 patientsJ P Greer, W R Macon, R E Lamar, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|July 6, 2016
Reduced-Intensity Conditioning with Fludarabine, Cyclophosphamide, and Rituximab Is Associated with Improved Outcomes Compared with Fludarabine and Busulfan after Allogeneic Stem Cell Transplantation for B Cell MalignanciesVanessa E Kennedy, Bipin N Savani, John P Greer, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 1, 1993
Effective therapy for poor-prognosis non-Hodgkin's lymphoma with 8 weeks of high-dose-intensity combination chemotherapyT M Waits, F A Greco, J P Greer, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 1, 1991
Clinical features of 31 patients with Ki-1 anaplastic large-cell lymphomaJ P Greer, M C Kinney, R D Collins, et al.
Seminars in Oncology|June 1, 1987
High-dose cytosine arabinoside and daunorubicin as consolidation therapy for acute nonlymphocytic leukemia in first remission: an updateS N Wolff, R H Herzig, G L Phillips, et al.
Pageof 18

Showing results (121-130 of 178) with videos related to

Sort By:
Pageof 18
Leukemia & Lymphoma|May 9, 2001
Is total body irradiation a necessary component of preparative therapy for autologous transplantation in non-Hodgkin's lymphomaR S Stein, J P Greer, S Goodman, et al.
Journal of Crohn'S & Colitis|October 17, 2013
Costs of adalimumab versus infliximab as first-line biological therapy for luminal Crohn's diseaseGrace K H Choi, Stephanie D E Collins, Daniel P Greer, et al.
Technology in Cancer Research & Treatment|September 26, 2019
Investigation of a Novel Decision Support Metric for Head and Neck Adaptive Radiation Therapy Using a Real-Time <i>In Vivo</i> Portal Dosimetry SystemS B Lim, C J Tsai, Y Yu, et al.
Bone Marrow Transplantation|February 16, 2000
Intensified preparative regimens and autologous transplantation in refractory or relapsed intermediate grade non-Hodgkin's lymphomaR S Stein, J P Greer, S Goodman, et al.
Cancer|December 1, 1987
Malignant lymphomas of follicular center cell origin in man. VI. Large cleaved cell lymphomaR S Stein, M J Magee, R K Lenox, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 1, 1995
T-cell-rich B-cell lymphomas: diagnosis and response to therapy of 44 patientsJ P Greer, W R Macon, R E Lamar, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|July 6, 2016
Reduced-Intensity Conditioning with Fludarabine, Cyclophosphamide, and Rituximab Is Associated with Improved Outcomes Compared with Fludarabine and Busulfan after Allogeneic Stem Cell Transplantation for B Cell MalignanciesVanessa E Kennedy, Bipin N Savani, John P Greer, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 1, 1993
Effective therapy for poor-prognosis non-Hodgkin's lymphoma with 8 weeks of high-dose-intensity combination chemotherapyT M Waits, F A Greco, J P Greer, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 1, 1991
Clinical features of 31 patients with Ki-1 anaplastic large-cell lymphomaJ P Greer, M C Kinney, R D Collins, et al.
Seminars in Oncology|June 1, 1987
High-dose cytosine arabinoside and daunorubicin as consolidation therapy for acute nonlymphocytic leukemia in first remission: an updateS N Wolff, R H Herzig, G L Phillips, et al.
Pageof 18